Abstract
This review discusses the mineral bone disorders in patients with chronic kidney disease. We focus on the management of these conditions by administration of calcium, vitamin D (ergocalciferol and cholecalciferol), vitamin D receptor activators (calcitriol, alphacalcidiol), phosphate binders and calcimimetics (cinacalcet).
| Bidragets oversatte titel | Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 174 |
| Udgave nummer | 47 |
| Sider (fra-til) | 2931-4 |
| Antal sider | 4 |
| ISSN | 0041-5782 |
| Status | Udgivet - 2012 |